GlaxoSmithKline Pharmaceuticals Limited (GLAXO.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 386.78B |
| Enterprise Value | 376.09B |
| P/E Ratio | 46.03 |
| PEG Ratio | 3.72 |
| Price/Sales Ratio | 12.43 |
| Price/Book Ratio | 21.68 |
| Enterprise/Revenue | 12.43 |
| Enterprise/EBITDA | 32.36 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.27 |
| Operating Margin | 0.33 |
AD
Management Effectiveness
| Return On Assets | 0 |
| Return On Equity | 0.54 |
Income Statement
| Revenue | 38.22B |
| Revenue/Share | 233.46 |
| Gross Profit | 16.65B |
| EBITDA | 14.75B |
| Net Income | 10.36B |
| Diluted EPS | 61.15 |
Balance Sheet
| Total Cash | 27.57B |
| Total Cash/Share | 0 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 0 |
| Book Value Per Share | 133.85 |
Price History
| 52-Week Change | 3.69 |
| 52-Week High | 3,054.9 |
| 52-Week Low | 2,088.1 |
| Moving Average 50 Days | 2,516.95 |
| Moving Average 200 Days | 2,450.34 |
Statistics
| Average Volume | 133,646 |
| Shares Outstanding | 169.41M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 57 |
| Trailing Annual Dividend Yield | 1.96 |
| Payout Ratio | 0.67 |
| Last Split Factor | 2:1 |
| Last Split Date | September 11, 2018 |
AD
